Health

Ebangla Bureau Vaccines of Serum Institute of India and Bharat Biotech are  granted permission for restricted use in emergency situation,

World Health Organization welcomes India’s decision giving emergency use authorization to COVID19 vaccines, said  Dr Poonam Khetrapal Singh, Regional Director,

Ebangla Bureau India’s Minister for Health and Family Welfare Dr Harsh Vardhan said on Saturday, January 2 that in the

AFTER COVISHIELD, expert panel recommends granting conditional approval for restricted emergency use of  COVID vaccine Covaxin.  Covaxin, the indigenous Covid-19

India with the world’s second-highest number of COVID-19 infections in the world after the United States, is set to launch

Ebangla Bureau AN  expert panel has recommended affordable Oxford vaccine to the drugs regulator DGCI for India in the fight

AS Geneva headquartered World Health Organisation asserts the new COVID-19 virus is ‘’NOT out of Control, India’s Minister for Health